Clinical observation on efficacy of anti-virus oral liquid on herpangina

Abstract

Abstract: AIM: To observe the effects of anti-virus oral liquid on herpangina in children.METHODS: Three hundreds and sixty children with herpangina were randomly allocated into three groups, treated with ribavirin spray, anti-virus oral liquid, ribavirin spray combined with anti-virus oral liquid, respectively.RESULTS: There were no differences of defervescence, regression time of herpes and total efficacy rate between ribavirin spray treatment group and anti-virus oral liquid control group (P<0.05), ribavirin spray combined with anti-virus oral liquid treatment could further shorten the defervescence and regression time of herpes, increased the total efficacy rate (P>0.05).CONCLUSION: Anti-virus oral liquid has an affirmative clinical efficacy in the treatment of children with herpangina, especially combined with ribavirin spray.

Key words: Anti-virus oral liquid, Ribavirin spray, Herpangina

CLC Number:

R725

LIU Ai-lin, LI Li. Clinical observation on efficacy of anti-virus oral liquid on herpangina[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(7): 796-799.

References

[1] Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management[J]. Expert Rev Anti Infect Ther, 2009, 7(6):735-742.
[2] Miyazawa I, Azegami Y, Kasuo S, et al. Prevalence of enterovirus from patients with herpangina and hand, foot and mouth disease in Nagano Prefecture, Japan, 2007[J]. Jpn J Infect Dis, 2008, 61(3):247-248.
[3] Tseng FC, Huang HC, Chi CY, et al. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data[J]. J Med Virol, 2007, 79(12):1850-1860.
[4] 何梅玲, 彭丰. 喜炎平注射液治疗疱疹性咽峡炎疗效观察[J]. 中国误诊学杂志, 2010, 10(10):2349-2350.
[5] 党林蓉. 炎琥宁治疗疱疹性咽峡炎110例疗效观察[J]. 临床合理用药, 2009, 2(5):18-19.
[6] 卫生部. 手足口病诊疗指南[S]. 2010.
[7] 黄小民, 柳于介, 何煜舟, 等. 热毒宁注射液治疗急性上呼吸道感染的临床研究[J]. 中国临床药理学与治疗学, 2006, 11(4):470-473.
[8] 张建民, 庹玉玲, 关晶. 抗病毒口服液的抗病毒作用实验研究[J]. 北京医学, 2008, 30(7):445-446.
[9] 刘湘云. 诸福棠实用儿科学[J]. 7版. 北京:人民卫生出版社, 2002: 807-808.
[10] 王华芳, 郦建娣, 赵小芳. 利巴韦林气雾剂治疗疱疹性咽峡炎疗效观察[J]. 中国当代儿科杂志, 2009, 11(6):494-495.
[11] 戴宪国, 方洪兴, 莫纯坚. 更昔洛韦治疗疱疹性咽峡炎162例疗效观察[J]. 中国误诊学杂志, 2006, 6(3):465-466.
[12] 甑娇岚. 阿昔洛韦治疗疱疹性咽峡炎108例疗效观察[J]. 中国实用儿科杂志, 2002, 17(5):317.
[13] Chavez-Bueno S, Mejias A, Merryman RA, et al. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients[J]. Pediatr Infect Dis J, 2007, 26(12):1089-1093.
[14] 荆爱霞, 孙素杰, 赵志霞. 抗病毒口服液治疗小儿疱疹性咽峡炎50例[J]. 云南中医中药杂志, 2008, 29(7):37-38.

[1]	ZHANG Qiang, ZHENG Huajun, LI Quan. Research progress on the treatment of autism spectrum disorders based on gut microbiota intervention [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 475-480.
[2]	WANG Yuanyuan, HONG Yu, ZHANG Lei, YIN Fangxiong, LEI Ting, ZHU Xi. Establishment and application of DUE criteria for human albumin in pediatric patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 653-661.
[3]	WANG Shibiao, WANG Chengyi, WENG Bin, GUO Xiaofeng, LIN Hai. Comparison of the efficacy of non-invasive USCOM and milrinone in children with severe pneumonia and heart failure and its effect on brain natriuretic peptide levels [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1402-1407.
[4]	LV Xiaojuan, TANG Weihong, WANG Huiting, WANG Zhongmin, GUAN Minchang, LI Haifeng. Efficacy and safety analysis of fiberoptic bronchoscopy combined with methylprednisolone in children with RMPP [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 1040-1046.
[5]	ZHU Tingfu, ZOU Chaochun. Clinical effect of Bailing capsule in children with diabetic renal injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 912-915.
[6]	MAO Qingdong. Efficacy and safety of recombinant human interferon alfa2b oxygen inbreathe for bronchiolitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 927-931.
[7]	LUO Lingling, TENG Chengzhi, LI Xiaoxiao, PAN Danfeng. Clinical trial of azithromycin combined with ambroxol hydrochloride in treatment of mycoplasma pneumonia children with acute bronchial pneumonia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1278-1282.
[8]	ZHANG Peihong, CHEN Xiaohong, CHEN Bingrong, LI Huajun. Study on asthmatic children serum cytokine levels and saccharomyces boulardii intervention [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(3): 332-336.
[9]	MA Lu, GUO Xiao-yuan, PI Wen-xia. Clinical observation of montelukast sodium for treatment of wheezing infants of non-specific symptoms [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(11): 1300-1303.
[10]	FENG Si-guo, ZHONG Xiao-rong. Comparison on curative effects between domestic and imported pulmonary surfactant on neonatal respiratory distress syndrome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 296-299.
[11]	. [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(3): 243-243.
[12]	HU Qun-sheng. Clinical observation of children bronchiolitis therapy with combination of interferon and pulmicort respules [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(6): 704-706.
[13]	HUANG Hui, LIU Ya-li. Effects of Bacille Calmette Guerin on immunological function of infants with bronchiolitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(3): 342-345.
[14]	ZHOU Dong-ping. Meta-analysis of lactobacillus for children acute diarrhoea [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(6): 627-631.
[15]	YAO Huan-yin, ZHANG Pei-hong, WANG Xiao-xian, WANG Wei, LIU Shu-mei, CHEN Xiao-hong. Effect of montelukast on the level of urine leukotriene E4 in children with bronchiolitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 441-444.